[Therapeutic effect of piracetam in a case of posthypoxic action myoclonus (author's transl)]. 1978

G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon

Since the advent of intensive care units the number of cases of posthypoxic action or intention myoclonus has greatly increased. This has given rise to renewed research into the physiopathology and therapy of the disease. The latent effective treatment is based on derivatives of benzodiazepine, and especially L-5-hydroxytryptophan, administered with or without an inhibitor of peripheral decarboxylase. The disadvantages of these compounds, associated with their secondary effects, make our fortuitous discovery of the effectively curative action of piracetam doubly valuable.

UI MeSH Term Description Entries
D009207 Myoclonus Involuntary shock-like contractions, irregular in rhythm and amplitude, followed by relaxation, of a muscle or a group of muscles. This condition may be a feature of some CENTRAL NERVOUS SYSTEM DISEASES; (e.g., EPILEPSY, MYOCLONIC). Nocturnal myoclonus is the principal feature of the NOCTURNAL MYOCLONUS SYNDROME. (From Adams et al., Principles of Neurology, 6th ed, pp102-3). Myoclonus, Action,Myoclonus, Nocturnal,Myoclonus, Palatal,Polymyoclonus,Myoclonic Jerk,Myoclonic Jerking,Myoclonus Simplex,Myoclonus, Eyelid,Myoclonus, Intention,Myoclonus, Lower Extremity,Myoclonus, Oculopalatal,Myoclonus, Segmental,Myoclonus, Sleep,Myoclonus, Upper Extremity,Action Myoclonus,Extremity Myoclonus, Lower,Extremity Myoclonus, Upper,Eyelid Myoclonus,Intention Myoclonus,Jerk, Myoclonic,Jerking, Myoclonic,Jerks, Myoclonic,Lower Extremity Myoclonus,Myoclonic Jerks,Nocturnal Myoclonus,Oculopalatal Myoclonus,Palatal Myoclonus,Segmental Myoclonus,Simplex, Myoclonus,Sleep Myoclonus,Upper Extremity Myoclonus
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006323 Heart Arrest Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation. Asystole,Cardiac Arrest,Cardiopulmonary Arrest,Arrest, Cardiac,Arrest, Cardiopulmonary,Arrest, Heart,Asystoles
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies

Related Publications

G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
January 1986, Advances in neurology,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
January 2016, Movement disorders clinical practice,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
November 2001, The Journal of the Association of Physicians of India,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
April 2020, BMJ case reports,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
January 1986, Advances in neurology,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
November 1971, JAMA,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
February 1992, Presse medicale (Paris, France : 1983),
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
January 1982, Acta biologica et medica Germanica,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
February 1996, European journal of pharmacology,
G Terwinghe, and J Daumerie, and C Nicaise, and O Rosillon
September 1994, European journal of emergency medicine : official journal of the European Society for Emergency Medicine,
Copied contents to your clipboard!